![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
March 30, 2026
The co-chairs reflect on the rapidly evolving definition of sensitive research data and highlight priorities for building secure data environments that sustain patient protection and public trust
February 27, 2026
Progress in geriatric oncology, reflections on regulatory complexity, and an exciting new trial in small cell lung cancer
January 30, 2026
The co-chairs reflect on last year's key research advances and highlight priorities for 2026
December 19, 2025
Highlights from SABCS featuring new multimodal AI models developed by ECOG-ACRIN and Caris to advance recurrence risk assessment and personalized care in early-stage breast cancer
November 21, 2025
A recap of the Fall 2025 Group Meeting, trial results from ESMO, and a look ahead to the ASH Annual Meeting and Exposition and the San Antonio Breast Cancer Symposium
October 17, 2025
A welcome to the new National Cancer Institute director, an update on the federal budget and its implications, and a look ahead to next week's Group Meeting
September 19, 2025
An update on the cancer research environment, a recap of the September NCAB meeting, and a preview of the fall group meeting
August 28, 2025
An open letter from the NCTN Cooperative Group Chairs to Congress on the importance of supporting robust federal funding for cancer research
July 10, 2025
A call to champion federally-funded cancer research, a discussion on limited radiation exposure from CT scans, and a TAILORx trial update
June 11, 2025
Grant updates; engineering and cancer research; Spring Group Meeting and ASCO highlights
April 24, 2025
An update on the Group's activity; a new Central Biorepository and Pathology Facility director; a preview of key Group Meeting sessions
March 21, 2025
An update on the NCTN Grant; upcoming Group Meeting highlights; a perspective on the mistrust of science